HCA Healthcare, Inc. (NYSE:HCA) is Intrust Bank NA’s 9th Largest Position

Intrust Bank NA lessened its stake in HCA Healthcare, Inc. (NYSE:HCA) by 0.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 58,936 shares of the company’s stock after selling 538 shares during the quarter. HCA Healthcare comprises about 1.8% of Intrust Bank NA’s holdings, making the stock its 9th largest holding. Intrust Bank NA’s holdings in HCA Healthcare were worth $17,690,000 as of its most recent filing with the SEC.

Several other large investors also recently added to or reduced their stakes in the stock. First Eagle Investment Management LLC lifted its holdings in HCA Healthcare by 0.5% in the fourth quarter. First Eagle Investment Management LLC now owns 4,503,849 shares of the company’s stock valued at $1,351,830,000 after acquiring an additional 23,177 shares during the last quarter. Norges Bank purchased a new position in shares of HCA Healthcare during the 4th quarter worth $840,286,000. Franklin Resources Inc. lifted its position in HCA Healthcare by 11.7% in the third quarter. Franklin Resources Inc. now owns 1,669,721 shares of the company’s stock valued at $660,842,000 after buying an additional 174,946 shares during the last quarter. Royal London Asset Management Ltd. increased its position in shares of HCA Healthcare by 62.0% during the fourth quarter. Royal London Asset Management Ltd. now owns 1,500,786 shares of the company’s stock valued at $450,461,000 after acquiring an additional 574,239 shares during the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of HCA Healthcare by 2.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,487,367 shares of the company’s stock worth $604,511,000 after acquiring an additional 41,190 shares during the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares in the company, valued at approximately $4,971,757.08. This represents a 38.22 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 1.30% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts have commented on HCA shares. Bank of America decreased their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a research note on Monday, January 27th. Truist Financial dropped their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Royal Bank of Canada dropped their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating for the company in a report on Monday, January 27th. KeyCorp decreased their price target on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Finally, Cantor Fitzgerald reiterated an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research note on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $385.67.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $342.25 on Friday. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $417.14. The company’s fifty day moving average is $324.53 and its two-hundred day moving average is $341.56. The firm has a market capitalization of $84.26 billion, a P/E ratio of 15.58, a PEG ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period in the previous year, the company posted $5.90 EPS. Analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be given a dividend of $0.72 per share. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.84%. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s payout ratio is presently 13.11%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.